AKT1 and lung carcinoma: Analogue of α-conotoxin RgIA–RgIA4 (Table 1), potent antagonist of both rat and human α9α10 nAChRs, in a similar way inhibited nicotine-induced cell proliferation of A549 lung cancer cells via the p-Akt and p-ERK pathways [17].